Press releases, Investors Press releases, Investors17 April 2026parDIAGNOS DIAGNOS-presentera-des-solutions-dIA-de-pointe-pour-la-sante-retinienne-a-ARVO-2024 Post navigation Previous PostDIAGNOS-Q3-2024-Financial-Statements-1 Next PostDIAGNOS-to-Present-Cutting-Edge-AI-Solutions-for-Retinal-Health-at-ARVO-2024 Ressources connexe <img src="/wp-content/uploads/2026/04/WhatsApp-Image-2026-04-23-at-12.41.28.jpeg" alt="DIAGNOS-accelerera-la-demande-de-licence-dinstrument-medical-a-Sante-Canada-et-a-la-FDA-des-Etats-Unis-concernant-ses-4-nouveaux-modules-danalyse^J-et-prevoit-la-certification-ISO-27001" class="attachment-pbmit-img-890x660 size-pbmit-img-890x660 wp-post-image" width="890" height="660" > Press releases Investors 04 2024 DIAGNOS DIAGNOS accelerera la demande de licence dinstrument medical a Sante Canada et a la FDA des Etats Unis concernant ses 4 nouveaux modules danalyse^J et prevoit la certification ISO 27001 Download PDF <img src="/wp-content/uploads/2026/04/WhatsApp-Image-2026-04-23-at-12.41.28.jpeg" alt="DIAGNOS-Announces-Amendment-to-Convertible-Debentures" class="attachment-pbmit-img-890x660 size-pbmit-img-890x660 wp-post-image" width="890" height="660" > Press releases Investors 03 2025 DIAGNOS DIAGNOS Announces Amendment to Convertible Debentures Download PDF <img src="/wp-content/uploads/2026/04/WhatsApp-Image-2026-04-24-at-00.28.18.webp" alt="DIAGNOS initiates a clinical trial study in the USA commencing December 6th 2021" class="attachment-pbmit-img-890x660 size-pbmit-img-890x660 wp-post-image" width="890" height="660" > Resource center Investors 11 2021 DIAGNOS DIAGNOS initiates a clinical trial study in the USA commencing December 6th 2021 Download PDF
<img src="/wp-content/uploads/2026/04/WhatsApp-Image-2026-04-23-at-12.41.28.jpeg" alt="DIAGNOS-accelerera-la-demande-de-licence-dinstrument-medical-a-Sante-Canada-et-a-la-FDA-des-Etats-Unis-concernant-ses-4-nouveaux-modules-danalyse^J-et-prevoit-la-certification-ISO-27001" class="attachment-pbmit-img-890x660 size-pbmit-img-890x660 wp-post-image" width="890" height="660" > Press releases Investors 04 2024 DIAGNOS DIAGNOS accelerera la demande de licence dinstrument medical a Sante Canada et a la FDA des Etats Unis concernant ses 4 nouveaux modules danalyse^J et prevoit la certification ISO 27001 Download PDF
<img src="/wp-content/uploads/2026/04/WhatsApp-Image-2026-04-23-at-12.41.28.jpeg" alt="DIAGNOS-Announces-Amendment-to-Convertible-Debentures" class="attachment-pbmit-img-890x660 size-pbmit-img-890x660 wp-post-image" width="890" height="660" > Press releases Investors 03 2025 DIAGNOS DIAGNOS Announces Amendment to Convertible Debentures Download PDF
<img src="/wp-content/uploads/2026/04/WhatsApp-Image-2026-04-24-at-00.28.18.webp" alt="DIAGNOS initiates a clinical trial study in the USA commencing December 6th 2021" class="attachment-pbmit-img-890x660 size-pbmit-img-890x660 wp-post-image" width="890" height="660" > Resource center Investors 11 2021 DIAGNOS DIAGNOS initiates a clinical trial study in the USA commencing December 6th 2021 Download PDF
